New findings could help improve development of drugs for addiction

August 2, 2013

Scientists from the Florida campus of The Scripps Research Institute have described findings that could enable the development of more effective drugs for addiction with fewer side effects.

The study, published in the August 2, 2013 issue of the Journal of Biological Chemistry, showed in a combination of cell and animal studies that one active compound maintains a strong bias towards a single , providing insight into what future drugs could look like.

The compound examined in the study, known as 6'- guanidinonaltrindole (6'-GNTI), targets the kappa (KOR). Located on , KOR plays a role in the release of dopamine, a neurotransmitter that plays a key role in . Drugs of abuse often cause the brain to release large amounts of dopamine, flooding the brain's reward system and reinforcing the addictive cycle.

"There are a number of drug discovery efforts ongoing for KOR," said Laura Bohn, a TSRI associate professor, who led the study. "The ultimate question is how this receptor should be acted upon to achieve the best therapeutic effects. Our study identifies a marker that shows how things normally happen in live neurons—a critically important secondary test to evaluate potential compounds."

While KOR has become the focus for drug discovery efforts aimed at treating addiction and mood disorders, KOR can react to signals that originate independently from multiple biological pathways, so current drug candidates targeting KOR often produce unwanted side effects. Compounds that activate KOR can decrease the rewarding effects of abused drugs, but also induce sedation and depression.

The new findings, from studies of nerve cells in the striatum (an area of the brain involved in motor activity and higher ), reveal a point on the KOR signaling pathway that may prove to be an important indicator of whether drug candidates can produce effects similar to the natural biological effects.

"Standard screening assays can catch differences but those differences may not play out in live tissue," Bohn noted. "Essentially, we have shown an important link between cell-based screening assays and what occurs naturally in animal models."

Explore further: Receptor limits the rewarding effects of food and cocaine

More information: "Functional Selectivity of 6'-guanidinonaltrindole (6'-GNTI) at Kappa Opioid Receptors in Striatal Neurons,"

Related Stories

Receptor limits the rewarding effects of food and cocaine

July 12, 2011

(Medical Xpress) -- Researchers have long known that dopamine, a brain chemical that plays important roles in the control of normal movement, and in pleasure, reward and motivation, also plays a central role in substance ...

A path to lower-risk painkillers

June 10, 2013

For patients managing cancer and other chronic health issues, painkillers such as morphine and Vicodin are often essential for pain relief. The body's natural tendency to develop tolerance to these medications, however, often ...

Brain implant aims to stifle drug highs

July 29, 2013

What happens if addicts get no high from the drugs they take? Researchers at Case Western Reserve and Illinois State universities have received a $390,000 National Institute on Drug Abuse grant to help answer the question.

Recommended for you

Scientists convert skin cells into placenta-generating cells

October 12, 2015

Regenerative medicine is a new and expanding area that aims to replace lost or damaged cells, tissues or organs in the human body through cellular transplantation. Embryonic stem cells (ESCs) are pluripotent cells that are ...

Genes linked with malaria's virulence shared by apes, humans

October 12, 2015

The malaria parasite molecules associated with severe disease and death—those that allow the parasite to escape recognition by the immune system—have been shown to share key gene segments with chimp and gorilla malaria ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.